Steven Cohen's ALXO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 41,095 shares of ALX Oncology Holdings Inc. (ALXO) worth $82,396, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ALXO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 913,700 shares. Largest reduction occurred in Q1 2024, reducing 913,700 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's ALX Oncology Holdings (ALXO) Holding Value Over Time
Track share changes against reported price movement
Quarterly ALX Oncology Holdings (ALXO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +20,878 | Add 103.27% | 41,095 | $2.01 |
| Q4 2025 | +20,217 | New Buy | 20,217 | $1.13 |
| Q3 2024 | -304,100 | Sold Out | 0 | $0.00 |
| Q2 2024 | +304,100 | New Buy | 304,100 | $6.03 |
| Q1 2024 | -913,700 | Sold Out | 0 | $0.00 |
| Q4 2023 | +913,700 | New Buy | 913,700 | $14.89 |
| Q2 2023 | -13,556 | Sold Out | 0 | $0.00 |
| Q1 2023 | -71,444 | Reduce 84.05% | 13,556 | $4.52 |
| Q4 2022 | -297,500 | Reduce 77.78% | 85,000 | $11.27 |
| Q3 2022 | +382,500 | New Buy | 382,500 | $9.57 |
Steven Cohen's ALX Oncology Holdings Investment FAQs
Steven Cohen first purchased ALX Oncology Holdings Inc. (ALXO) in Q3 2022, acquiring 382,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held ALX Oncology Holdings Inc. (ALXO) for 10 quarters since Q3 2022.
Steven Cohen's largest addition to ALX Oncology Holdings Inc. (ALXO) was in Q4 2023, adding 913,700 shares worth $13.6 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 41,095 shares of ALX Oncology Holdings Inc. (ALXO), valued at approximately $82,396.
As of the Q1 2026 filing, ALX Oncology Holdings Inc. (ALXO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in ALX Oncology Holdings Inc. (ALXO) was 913,700 shares, as reported at the end of Q4 2023.